The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. The cookie is used to store the user consent for the cookies in the category "Performance". This cookie is set by GDPR Cookie Consent plugin. the board chairperson and the CEO and with the president of the medical staff if. The cookies is used to store the user consent for the cookies in the category "Necessary". The CEO, as the name implies, executes to fulfill the values and meet. The cookie is used to store the user consent for the cookies in the category "Other. The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". The cookie is used to store the user consent for the cookies in the category "Analytics". These cookies ensure basic functionalities and security features of the website, anonymously. Necessary cookies are absolutely essential for the website to function properly.
Leslie received her undergraduate degree from Northwestern University and her MBA from the Haas School of Business, UC Berkeley. She began her medical device career at Guidant Corporation. Danielle Harlan, PhD, Founder and CEO of the Center For Advancing. Leslie’s management experience also includes senior leadership positions at Cytyc Corporation and breast cancer diagnostics company Pro-Duct Health, Inc., which was acquired by Cytyc. Stacey Porter, VP People and Operations, Outset Medical Successful leaders start with.
Before joining AccessClosure, Leslie served as Vice President, Marketing for FoxHollow Technologies, helping to architect the strategy and commercial infrastructure that led to a successful IPO and subsequent acquisition by ev3/Covidien. Responsible for driving operational excellence and corporate strategy across Supply Chain, Manufacturing, Product Realization, and QA/RA functions at Outset. Prior to Lutonix, Leslie served as Chief Business Officer of AccessClosure, a vascular closure company acquired by Cardinal Health. Previously, she was Executive Vice President at Lutonix, a cardiovascular medical device company acquired by CR Bard. Leslie joined Outset from Warburg Pincus where she was an Executive in Residence. Leslie has served as our Chief Executive Officer since November 2014 and was elected Chair in 2022.
0 kommentar(er)
